Marker Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.About MRKR
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
MRKR Key Statistics
Stock Snapshot
With a market cap of 19.51M, Marker Therapeutics(MRKR) trades at $1.18. The stock has a price-to-earnings ratio of -2.46.
As of 2026-09-18, Marker Therapeutics(MRKR) stock has fluctuated between $1.13 and $1.23. The current price stands at $1.18, placing the stock +4.4% above today's low and -3.7% off the high.
Marker Therapeutics(MRKR) shares are trading with a volume of 60.59K, against a daily average of 59.13K.
During the past year, Marker Therapeutics(MRKR) stock moved between $0.84 at its lowest and $2.46 at its peak.
During the past year, Marker Therapeutics(MRKR) stock moved between $0.84 at its lowest and $2.46 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.